Skip to main
NRXP
NRXP logo

NRX Pharmaceuticals (NRXP) Market Capitalization Overview

Market Cap: $65.93M as of Jul 3, 2025

$65.93M
Past Month+$19.59M (42.27%)
As of Jul 3, 2025, NRX Pharmaceuticals (NRXP) has a market capitalization of $65.93M. Over the past 30 days, its market cap has increased by 31.75%, while in the last 12 months, it has increased by 147.76%.

Market capitalization represents the total value of NRX Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NRX Pharmaceuticals (NRXP) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NRX Pharmaceuticals (NRXP) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NRX Pharmaceuticals (NRXP) Market Cap History

DateMarket CapChange
Jul 1, 2025$61.05M+31.75%
Jun 2, 2025$46.34M+31.69%
May 1, 2025$35.19M+7.22%
Apr 1, 2025$32.82M-4.43%
Mar 3, 2025$34.34M+1.40%
Feb 3, 2025$33.87M-6.35%
Jan 2, 2025$36.17M+121.48%

NRX Pharmaceuticals (NRXP) End of Year Market Cap History

DateMarket CapChange
2025$65.93M+147.76%
2024$26.61M-31.08%
2023$38.61M-48.59%
2022$75.09M-73.29%
2021$281.12M+328.57%
2020$65.60M

FAQs About NRX Pharmaceuticals (NRXP) Market Cap

As of Jul 3, 2025, the market capitalization of NRX Pharmaceuticals (NRXP) is $65.93M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, NRX Pharmaceuticals’s market capitalization has increased by 42.27%, changing from $46.34M to $65.93M as of Jul 3, 2025.

In the last 3 months, NRX Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, NRX Pharmaceuticals’s market capitalization decreased from $38.61M in January to $26.61M in December, reflecting a -31.08% change.

In the past five years, NRX Pharmaceuticals (NRXP) has had a compound annual growth rate (CAGR) of -16.51% in market capitalization. This means its market cap has shrunk at an average rate of -16.51% per year.

NRX Pharmaceuticals (NRXP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.